Importance of Vitamin D Status and Nerve Conduction in Pediatric Cystic Fibrosis Patients

Abstract

Cystic fibrosis is one of the most common inherited diseases. It presents with recurrent respiratory infections, pancreatic insufficiency, and growth retardation. Neurological involvement becomes more common as life expectancy increases. Chronic hypoxia, impaired glucose intolerance, autoimmune mechanisms, vasculitis changes, and micronutrient deficiencies seem to cause neuropathy in cystic fibrosis. This study was aimed to investigate peripheral neuropathy in pediatric cystic fibrosis patients. Twenty-one cystic fibrosis patients and 19 healthy control subjects between the ages of 7 and 17 years were included. Their nerve conduction study results and laboratory investigations were analyzed. Participants were classified into four groups; 1. Cystic fibrosis with vitamin D deficiency, 2. Cystic fibrosis with normal vitamin D levels, 3. Healthy subjects with vitamin D deficiency, 4. Healthy subjects with normal vitamin D levels. We found statistically significantly lower sensory median nerve sensorial nerve action potential, sensorial sural nerve conduction velocity, and motor peroneal nerve compound motor action potential in cystic fibrosis patients with vitamin D deficiency than in other cases. We also found that the main difference between cystic fibrosis and control groups was especially in patients with low vitamin D levels. Nerve damage starts at an early age, especially in cystic fibrosis patients especially those with vitamin D deficiency. Electrophysiological evaluation to assess neuropathy is important even in asymptomatic patients. Prevention of hypovitaminosis D is important to prevent neuropathy in cystic fibrosis patients.

Keywords

cystic fibrosis - nerve conduction studies - neuropathy - vitamin D

Publikationsverlauf

Eingereicht: 14. April 2022

Angenommen: 10. September 2022

Artikel online veröffentlicht:
30. Januar 2023

• References

• 1 De Boeck K. Cystic fibrosis in the year 2020: A disease with a new face. Acta Paediatr 2020; 109 (05) 893-899
• 2 Reznikov LR. Cystic fibrosis and the nervous system. Chest 2017; 151 (05) 1147-1155
• 3 Shteinberg M, Haq IJ, Polineni D, Davies JC. Cystic fibrosis. Lancet 2021; 397 (10290): 2195-2211
• 4 O'Riordan JI, Hayes J, Fitzgerald MX, Redmond J. Peripheral nerve dysfunction in adult patients with cystic fibrosis. Ir J Med Sci 1995; 164 (03) 207-208
• 5 Pincikova T, Nilsson K, Moen IE. et al; Scandinavian Cystic Fibrosis Study Consortium (SCFSC). Vitamin D deficiency as a risk factor for cystic fibrosis-related diabetes in the Scandinavian Cystic Fibrosis Nutritional Study. Diabetologia 2011; 54 (12) 3007-3015
• 6 Luo JJ, Dun NJ. Neuropathies and vitamin D deficiency. Muscle Nerve 2020; 62 (06) E88-E89
• 7 Landais A. Neurological complications of bariatric surgery. Obes Surg 2014; 24 (10) 1800-1807
• 8 Shehab D, Al-Jarallah K, Abdella N, Mojiminiyi OA, Al Mohamedy H. Prospective evaluation of the effect of short-term oral vitamin d supplementation on peripheral neuropathy in type 2 diabetes mellitus. Med Princ Pract 2015; 24 (03) 250-256
• 9 Wasnik S, Sharma I, Baylink DJ, Tang X. Vitamin D as a potential therapy for multiple sclerosis: where are we?. Int J Mol Sci 2020; 21 (09) 3102
• 10 Garcia-Carrasco M, Jiménez-Herrera EA, Gálvez-Romero JL. et al. Vitamin D and Sjögren syndrome. Autoimmun Rev 2017; 16 (06) 587-593
• 11 Chakrabarty B, Kabra SK, Gulati S. et al. Peripheral neuropathy in cystic fibrosis: a prevalence study. J Cyst Fibros 2013; 12 (06) 754-760
• 12 Gwathmey KG, Grogan J. Nutritional neuropathies. Muscle Nerve 2020; 62 (01) 13-29
• 13 Ryan CS, Conlee EM, Sharma R, Sorenson EJ, Boon AJ, Laughlin RS. Nerve conduction normal values for electrodiagnosis in pediatric patients. Muscle Nerve 2019; 60 (02) 155-160
• 14 Kang PB, McMillan HJ, Kuntz NL. et al; Professional Practice Committee of the American Association of Neuromuscular & Electrodiagnostic Medicine. Utility and practice of electrodiagnostic testing in the pediatric population: An AANEM consensus statement. Muscle Nerve 2020; 61 (02) 143-155
• 15 Kang PB. Pediatric nerve conduction studies and EMG. In: Blum AS, Rutkove SB. eds. The Clinical Neurophysiology Primer. New Jersey: Humana Press; 2007: 369-389
• 16 Kang PB. Normal values Tables. In: McMillan HJ, Kang PB. eds. Pediatric Electromyography. Switzerland: Springer; 2017: 373-378
• 17 El-Salem K, Aburahma S, Rawashdeh M. Peripheral nerve dysfunction in patients with cystic fibrosis. J Clin Neurophysiol 2010; 27 (03) 216-218
• 18 Franques J, Chiche L, De Paula AM. et al. Characteristics of patients with vitamin B12-responsive neuropathy: a case series with systematic repeated electrophysiological assessment. Neurol Res 2019; 41 (06) 569-576
• 19 Juhász MF, Varannai O, Németh D. et al. Vitamin D supplementation in patients with cystic fibrosis: a systematic review and meta-analysis. J Cyst Fibros 2021; 20 (05) 729-736
• 20 Daley T, Hughan K, Rayas M, Kelly A, Tangpricha V. Vitamin D deficiency and its treatment in cystic fibrosis. J Cyst Fibros 2019; 18 (2, suppl 2): S66-S73
• 21 Shehab D, Al-Jarallah K, Mojiminiyi OA, Al Mohamedy H, Abdella NA. Does vitamin D deficiency play a role in peripheral neuropathy in type 2 diabetes?. Diabet Med 2012; 29 (01) 43-49
• 22 Pincikova T, Paquin-Proulx D, Sandberg JK, Flodström-Tullberg M, Hjelte L. Clinical impact of vitamin D treatment in cystic fibrosis: a pilot randomized, controlled trial. Eur J Clin Nutr 2017; 71 (02) 203-205